Colorectal Cancer Drug Pipeline Analysis Report 2024
Colorectal Cancer Market Outlook The growing prevalence of colorectal cancer is a key driver of advancements in the drug pipeline, with an estimated 152,810 new cases anticipated in the United States in 2024. Colorectal Cancer Drug Pipeline Analysis This includes around 81,540 cases in men and 71,270 in women, underscoring the considerable healt